As of April 15, 2025, ProKidney (PROK) has a market cap of $1.74 billion USD. According to our data, ProKidney is ranked No.4194 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $1.74 B |
703.93%
|
Dec 31, 2024 | $0.22 B |
-5.06%
|
Dec 29, 2023 | $0.23 B |
-74.05%
|
Dec 30, 2022 | $0.88 B |
-30.71%
|
Dec 31, 2021 | $1.27 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Mesoblast
MESO
|
$1.37 B |
0.000 M
|
![]() Australia
|
![]() Vericel
VCEL
|
$2.11 B |
-0.000 M
|
![]() USA
|
![]() Organogenesis
ORGO
|
$0.55 B |
-0.000 M
|
![]() USA
|
![]() Lineage Cell Therapeutics
LCTX
|
$97.94 M |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
Market Cap | = | PROK Stock Price | * | PROK Shares Outstanding |
= | $0.71 | * | 0.13 B | |
= | $1.74 B |